Page 7 - Astrazeneca

Covid-19 vaccines are all highly protective against death, study shows

Efficacy against Covid-linked disease averaged about 85% after a full course, say University of Florida researchers.

Two doses of AstraZeneca vaccine 85-90% effective: Public Health England

Two doses of the Oxford/AstraZeneca vaccine are around 85 per cent to 90 per cent effective against symptomatic disease, Public Health England (PHE) has said

How some vaccines are helping nations to exit Covid faster than others

Messenger RNA shots developed by Moderna or Pfizer and BioNTech are better at stopping people from becoming contagious, shows evidence.

The way forward for firms

Indian firms need to prepare for export boom by vaccinating employees, their family members; and prioritise export market

Norway excludes AstraZeneca from vaccination campaign, says PM Erna Solberg

Norway has removed the vaccine against Covid-19 made by AstraZeneca from its inoculation campaign, Prime Minister Erna Solberg said.

Canadian province halts AstraZeneca first doses over blood clot concerns

Canada's largest province said Tuesday it will stop giving out first doses of the Oxford-AstraZeneca coronavirus vaccine due to concerns over its link to rare blood clots

European Union insists dispute with AstraZeneca is only contractual

The European Commission insisted Monday it still trusts the coronavirus vaccine developed by AstraZeneca and that its dispute with the Anglo-Swedish drugmaker is only contractual

Covid-19 vaccination: Germany allows J&J, AstraZeneca jabs for all adults

Germany is making the one-shot Johnson & Johnson coronavirus vaccine available to all adults as it did with the AstraZeneca vaccine, though the bulk of the expected deliveries is still some way off. Germany has recommended the AstraZeneca shot mainly for over-60s because of a rare type of blood clot seen in an extremely small number of recipients. But amid a push to get as many people inoculated as possible, the government decided to allow doctors' offices to vaccinate any adults with it -- putting aside a priority system under which the oldest and most vulnerable have been vaccinated first. Health Minister Jens Spahn said authorities decided Monday to take the same approach with the Johnson & Johnson vaccine, about which there are similar concerns. He estimated that 5 to 6 million over-60s in Germany still need to be vaccinated and that should be concluded by early June. Spahn said the largest deliveries from Johnson & Johnson, more than 10 million doses, are expected in .

After just Rs 18,000 cr profits in a decade, Serum, Bharat Biotech may earn big with Covid

For both companies, the pandemic presents a once-in-a-lifetime opportunity to earn hundreds of crores of rupees that could be ploughed back to fund further research and capacity expansion

Covid-19: European Union doesn't renew the order for AstraZeneca vaccine

The EU Commission did not renew its order for AstraZeneca's Covid-19 vaccine, the European Union's Internal Market Commissioner said

Gap between AstraZeneca doses can be as little as 4 weeks: Germany

Germany defends AstraZeneca pivot as key to speeding Covid vaccinations; experts warn on reduced efficacy with shorter gap

Jesse Jackson urges Biden to release AstraZeneca vaccine doeses for India

At a news conference in Chicago, American civil rights activist Rev Jesse Jackson said he would speak to Biden to immediately release 60 million doses of AstraZeneca vaccines to India

Study finds slightly increased blood clot rates after AstraZeneca Covid jab

A large study in Denmark, Norway has found slightly increased rates of vein blood clots, including in the brain, among adults who had received their first dose of the Oxford-AstraZeneca Covid vaccine

US President Biden hopes to send AstraZeneca vaccine to countries by July 4

President Joe Biden provided an update on White House on goals for providing AstraZeneca Covid-19 vaccines to countries by July 4

US lawmakers seek briefing on plans to export vaccines to other countries

A group of American lawmakers has sought from the Biden Administration a briefing on how they plan to provide Covid-19 vaccines to India and other countries experiencing a surge in coronavirus cases

AstraZeneca reports Covid vaccine sales of $275 mn, expects hit to ease

The results come after a bruising start to the year as the drugmaker struggles with production of its vaccine and faces a legal battle after cutting deliveries to Europe

AstraZeneca first-quarter Covid-19 vaccine revenue at $275 million

This is the first time the drugmaker has given financial details from the distribution and sales of its vaccine.

US won't release AstraZeneca's vaccine until sure about safety: Official

The US FDA will not release AstraZeneca's coronavirus vaccine for export to other countries until it is sure the doses have been manufactured to US quality standards and will be safe and effective

Rich countries' vaccine nationalism to backfire as Covid worsens in India

Variants emerging in India pose worldwide threat, experts say; India's vaccine shortages in part blamed on US export curbs

India expects biggest share of US doses of AstraZeneca vaccine: Report

On Monday, the White House said 10 mn of the 60 mn doses could be cleared for export 'in coming weeks' and the rest by June